Login to Your Account



AACR 2013

Cancer Immunotherapy: 'Living Drugs' Bring High Hopes, Issues

By Anette Breindl
Science Editor

Monday, April 15, 2013

WASHINGTON – At the annual meeting of the American Association for Cancer Research (AACR) last week, researchers were touting the potential of immunotherapies at the same time as they were trying to figure out how to meet their unique regulatory and developmental challenges.

To continue reading subscribe now to BioWorld Insight

Learn More about BioWorld Insight

Already a subscriber? Sign In or Buy now to activate your subscription